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Abstract 
Background: Marine algae consumption is linked to law cancer incidences in countries that traditionally consume 
marine products. Hence, Phytochemicals are considered as potential chemo-preventive and chemotherapeutic 
agents against cancer. We investigated the effects of the algal sulfated polysaccharide extract (ASPE) from the red 
marine alga L. papillosa on MDA-MB-231 human breast cancer cell line.
Methods: Flow cytometry analysis was performed to study the cell viability, cell cycle arrest and apoptosis. Changes 
in the expression of certain genes associated with cell cycle regulation was conducted by PCR real time analyses. 
Further investigations on apoptotic molecules was performed by ROS measurement and protein profiling.
Results: ASPE at low doses (10 µg/ml), inhibited cell proliferation, and arrested proliferating MDA-MB-231 cells at 
G1-phase. However, higher doses (50 µg/ml), triggered apoptosis in those cells. The low dose of ASPE also caused up-
regulation of Cip1/p21 and Kip1/p27 and down-regulation of cyclins D1, D2, and E1 transcripts and their related cyclin 
dependent kinases: Cdk2, Cdk4, and Cdk6. The higher doses of ASPE initiated a dose-dependent apoptotic death in 
MDA-MB-231 by induction of Bax transcripts, inhibition of Bcl-2 and cleavage of Caspase-3 protein. Over-generation 
of reactive oxygen species (ROS) were also observed in MDA-MB-231 treated cells.
Conclusions: These findings indicated that ASPE induces G1-phase arrest and apoptosis in MDA-MB-231 cells. ASPE 
may serve as a potential therapeutic agent for breast cancer.
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Background
Marine algae are health-enhancing resource for provid-
ing nutritional benefits and helping diseases treatment. 
Several epidemiological studies provided evidence that 
marine algae consumption correlates with low breast 
cancer rates in East-Asia. These studies report that low 
risks of developing breast cancer is associated with sea-
weeds intake in diet [1, 2]. The potentially beneficial 
effects of marine algae are partially attributed to poly-
saccharide compounds, particularly sulfated ones [3–5]. 
Carrageenans are a family of linear sulfated polysaccha-
ride (SP), extracted mainly from red algae [6–8]. Depend-
ing on their sulfation degree, solubility and gelling 
properties, three categories of carrageenans have been 
categorized as kappa-, iota- and lambda-carrageenans [9, 
10]. Red algae (Rhodophyta) have been documented as a 
source of natural nutraceuticals and pharmaceuticals for 
many years. Recent studies showed that sulfated poly-
saccharides isolated from red seaweed possesses various 
therapeutic and biological feature such as anti-oxidants 
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[11], anti-proliferative, anti-tumor [12–16], anti-viral [10, 
17] and anti-coagulants [18, 19].
Breast cancer is the most common cancer as well as the 
second leading cause of cancer-related deaths in women 
across the world. One out of ten women over 55  years 
of age is frequently diagnosed with breast cancer [20]. 
Dietary pattern has been identified as one of the major 
factors for the difference in breast cancer incidence [21]. 
Major issues concerning conventional anti-cancer chem-
otherapy are the occurrence of side effects induced by the 
non-specific targeting of both normal and cancerous cells 
[22, 23]. Based on this, there has been growing interest 
in the use of naturally occurring molecules with chemo-
preventive and chemotherapeutic properties in cancer 
treatment [3]. Natural products will thus continue to play 
major role as active substances, model molecules for the 
discovery and validation of new drug targets [24].
Breast cancer cell lines are useful tools for studying the 
mechanism of new nutraceuticals, pharmaceuticals and 
drugs effects on mammalian cells. MDA-MB-231 cell line 
is a human breast cancer cell line known to be widely used 
in such studies. A previous study indicated ASPE prepa-
ration from the red alga Laurencia papillosa. This ASPE 
predominantly contains a sulfated polysaccharide. ASPE 
could inhibit proliferation of MDA-MB-231 in  vitro in a 
time and dose dependent manner [25]. However, the anti-
proliferative activity mechanism of ASPE remains unclear. 
The purpose of the present study was to elucidate the 
mechanism of ASPE anti-proliferative effect. Furthermore, 
it was to characterize the cell cycle arrest and apoptosis 
induced in MDA-MB-231 cells after ASPE treatment.
Methods
Plant material collection and preparation of polysaccharide 
extract
Red alga L. papillosa was collected from Syrian coastal 
waters and processed at the marine biology labora-
tory (Faculty of biological sciences, Tishreen University, 
Syria). ASPE was prepared as previously explained in 
[25]. Briefly, collected algal biomass was washed with tap 
water to remove salt, sand and foreign matter, air-dried 
to constant weight at 60 °C then heated with water (1.5 % 
w/v) for 12  h with mechanical stirring. Polysaccharides 
then dissolved in MilliQ water and filtrated using cheese-
cloth and immediately mixed with 3 volumes of ethanol 
(95 %) (Sigma-Aldrich, Germany). This step caused pre-
cipitation of polysaccharides which were collected and 
oven-dried at 50–60 °C to constant weight.
Cell culture
MDA-MB-231 breast cancer cell line was kindly pro-
vided by prof. P. BÉCUWE, Cancer Research Unit (EA 
SIGRETO), Nancy, France. MDA-MB-231 cells were 
cultured in RPMI-1640 medium containing 10  % fetal 
bovine serum (FBS), 50  U/ml penicillin/streptomycin, 
and 2  m  M l-glutamine. Cells were treated with ASPE 
solved in water for the desired concentrations and times 
and proceeded for analysis as described below.
Cell viability assay
TO/PI double staining assay was used to distinguish 
dead cells from viable ones. 1 × 105 MDA-MB-231 cells 
were grown for 24  h (hours) then treated with differ-
ent concentrations of ASPE (5, 10, 50 and 100 µg/mL) or 
untreated (control), and incubated for another 24 h. Cell 
viability was estimated by adding 1 ml of viability buffer 
to labeled 6 ml tubes equals the number of samples to be 
analyzed. A 20–100 μl of each harvested cell suspension 
(~1 ×  105 cells) were transferred to the matching tubes. 
A 4 µl of Thiazole Orange (TO) solution (final concentra-
tion 1 µg/ml) and 2 µl of propidium iodide (PI) solution 
(final concentration 2 µg/ml) were added to each tube and 
incubated at room temperature for 5  min and analyzed 
directly on already set BD FACSCalibur flow cytometr.
DNA content/cell cycle analysis
Samples of untreated or treated MDA-MB-231 cell cut-
lers were analyzed for DNA content/cell cycle analysis 
by flow cytometry. Cell cycle distribution was calculated 
after appropriate gating of cell populations in FL-2-Area 
vs FL-2-Width plot of PI fluorescence. Assays were car-
ried out in triplicates, and the results are representative 
of three independent experiments.
Real‑time PCR array of human cell cycle related genes
Cells were seeded at 1 ×  106 cells and grown for 24  h, 
then treated with ASPE at two different concentrations: 
10 and 30 µg/mL for 24 h. Total RNA was extracted by 
RN easy kit (Qiagen, Hilden, Germany) and cDNA was 
synthesized as previously described [25]. For quantita-
tive determination of transcripts of cell cycle pathway, 
cDNA was mixed with RT2 SYBR Green ROX qPCR 
Master mix (SA Biosciences, USA) according to the 
manufacturer’s instructions. The expression of 84 genes 
was assessed using the Profiler™ PCR Array Human Cell 
Cycle (PAHS-020ZC-12, SA Biosciences, USA) according 
to the manufacturer’s instructions. Thermal cycling and 
fluorescence detection were performed using StepOne-
Plus™ Real-time PCR system (Applied Biosystems, Foster 
City, CA—USA). Data were analyzed by PCR array data 
analysis web portal (http://www.sabioscience.com/pcr/
arrayanalysis.php), using 2−ΔΔCt method.
Apoptosis assay
1  ×  105 MDA-MB-231 cells were seeded, and treated 
with ASPE with different concentrations: 10, 25 and 
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50  µg/mL. Untreated control was also included. Cells 
then incubated for 24 h. Cell death was evaluated by the 
loss of membrane integrity (high PI fluorescence) after 
treatment with PI solution. Phosphatidylserine expo-
sure was determined using Annexin V-FITC/PI double 
staining kit (BD Biosciences, USA) and analyzed by flow 
cytometry. Analysis of stained cells can distinguish cells 
into four groups, namely viable (annexin V− PI−), early 
apoptotic (annexin V+ PI−), late apoptotic (annexin V+ 
PI+) and necrotic (annexin V− PI+) cells.
Flow cytometry protein expression analysis
Cells were treated with ASPE for 24  h and then trypsi-
nized and centrifuged for 3 min at 130×g. The cells were 
re-suspended and washed with PBS. Active Caspase-3 
and Bcl-2 proteins expression were evaluated by fluo-
rochromes conjugated anti-bodies. For each protein a 
100 μl of cell suspension (~1 × 105 cells) were transferred 
to 5  ml tube. Cells washed twice with PBS containing 
1  % FCS and 0.1  % NaN3 then cells were suspended in 
250  µl of 1X fixation/permeabilization buffer, and incu-
bated in dark at 4 °C for 20 min. The cells washed twice 
with 1  ml of 1X permeabilization and washing buffer, 
and suspended in 100 perm/wash buffer. 20–30  μl of 
the fluorochrome conjugated anti-body was added and 
cells incubated on ice in the dark for 30 min. Then cells 
washed with 1 ml of PBS containing 1 % FCS and 0.1 % 
NaN3 and suspended in 500 µl of PBS. Appropriate iso-
type and autofluorescence controls were also included.
Measurement of released ROS
Mitochondrial function disorder is often associated 
with ROS release enhancement. The Amplex Red™, one 
kind of non-marking and oxidation-sensitive fluores-
cent probe, which detects the extracellular ROS released 
by the cell. This protocol was adapted for the measure-
ment of total released Hydrogen peroxide (H2O2) by 
lysing cells to detect the both intra- and extracellu-
lar produced H2O2 after ASPE treatment. Cells were 
seeded at 2 × 103 in 96-well plate before treatment then 
were treated with different concentrations of ASPE and 
incubated for 12  h. Cells were washed once with pre-
warmed 1 % triton added-sodium pyrophosphate buffer 
(25–200 mg/L) to prevent H2O2 degradation when cells 
lyses, then phosphate buffer containing the Amplex 
Red™ reagent was applied to the cells according to 
manufacturer’s instruction (Invitrogen, Carlsbad, USA). 
Plates were incubated for 15  min at 37  °C. Resorufin, 
the fluorescent product, was measured in triplicate by 
a fluorescence multi-well plate reader with an excita-
tion wavelength of 535 nm and an emission wavelength 
of 590 nm. The values were standardized with reference 
standard curve of H2O2.
Statistical analysis
The results were expressed as the mean value ±SEM of 
individual experiments. Comparisons of means were 
conducted using a one-way ANOVA followed by Bon-
ferroni’s post hoc test (GraphPad Prism-Version 6.0 for 
windows). We considered the two means significantly dif-
ferent when the P value associated was weaker than 0.05.
Results
Declines in MDA‑MB‑231 cell viability and cell death 
induction following ASPE exposure
In this study, the design of experiments focused firstly 
on investigating the response of ASPE-treated MDA-
MB-231 cells using different concentrations. The reduc-
tion in viability of treated cells was either due to the 
ASPE-induced cell death or may attribute to the inhibi-
tion of biological or biochemical function in cells exposed 
to ASPE. Our results showed insignificancy in dead cells 
in each of the cells exposed to 5 and 10 µg/mL (Fig. 1). 
In contrast, at a concentration of 50 µg/mL, the number 
of dead cells increased significantly to reach about 52 % 
at 24 h of exposure. By augmenting ASPE concentration, 
the number of dead cells doubled to reach almost 79  % 
of the population when cells were treated with 100  µg/
mL (Fig. 1). Thus, ASPE seems to be capable of exerting a 
cytotoxic effect on MDA-MB-231 cells under the present 
experimental conditions.
G1‑phase cell cycle arrest in MDA‑MB‑231 cells 
following ASPE exposure
ASPE-treated cells with different concentrations 10, 50 
and 100  µg/mL for 24  h showed a typical DNA pattern 
that represented sub-G1, G1, S, and G2/M phases of the 
cell cycle. Treated cells firstly showed higher G1 popu-
lation (73  %) compared with 60  % in the control when 
treated with 10  µg/mL ASPE. This treatment caused a 
concomitant decrease in the proportion of cells in G2/M 
phase of the cell cycle from control (20  %) to treated 
MDA-MB-231 cells (10 %) (Fig. 2). Whereas, the percent-
ages of sub-G1 phase (apoptotic cells) were significantly 
increased after cells were treated with 50 and 100 µg/mL 
ASPE up to 50 and 79 % respectively compared with 8 % 
in the control (Fig.  2). This experiment suggested that 
ASPE induces G1-phase cell cycle arrest at low concen-
tration (10  µg/mL). Consequently, ASPE treatment at 
higher concentrations (50  µg/mL) induced cell death in 
MDA-MB-231 cells.
Effect of ASPE on the expression levels of cell cycle 
regulatory genes in MDA‑MB‑231 cells
Meanwhile, we revealed ASPE injured DNA of MDA-
MB-231 cells and probably triggered the observed 
G1-phase cell cycle arrest by ASPE. We investigated 
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the effect of ASPE on the expression of cell cycle regu-
latory genes (cyclins, cyclin-dependent kinases “CDKs” 
and CDKs inhibitor). Treatment with ASPE resulted in 
a clear down-regulation in the gene expression levels of 
cyclin D1, cyclin D2 and cyclin E1 at 10 and 30 µg/mL 
(Fig.  3a). Similarly, a marked decrease in the expres-
sion of CDK2, CDK4 and CDK6 was detected at 24  h 
(Fig.  3a). Concomitantly, a significant increase in the 
expression of CDK inhibitory genes (Cip1/p21 and-
Kip1/p27) was observed (Fig.  3b). These results indi-
cate that ASPE induced at low concentration the CDK 
inhibitors which play a central role in the cell cycle 
progression and induced G1-phase arrest of in MDA-
MB-231 cells.
Fig. 1 Cytostatic effect of ASPE on MDA-MB-231 cells. Cell viability was determined by flow cytometry analysis after 24 h of ASPE treatment. 
Untreated (Cont), treated cells with different concentrations: 5 µg/mL (C5), 10 µg/mL (C10), 50 µg/mL (C50) and 100 µg/mL (C100). Viable and dead 
cells are expressed as a percentage of total cells of the control with each data point is representing the mean (±SEM) of three independent experi-
ments. Asterisks indicate significant difference (P < 0.05)
Fig. 2 ASPEeffect on the cell cycle distribution in MDA-MB-231 cell. Treated MDA-MB-231 cells with different concentrations of ASPE for 24 h were 
stained with PI to analyze the cell cycle distribution of each cell type by flow cytometry. Analysis of cell number % of each cell cycle phase relative 
to total phases. For example, sub-G1 % is calculated as the percentage of the number of cells in the sub-G1 population relative to the number of 
total cells. Untreated was indicated as (Cont) and treated cells were indicated as 10 µg/mL (C10), 50 µg/mL (C50) and 100 µg/mL (C100). Each data 
point represents the mean (±SEM) of three independent experiments. Asterisks indicate significant difference (P < 0.05)
Page 5 of 11Murad et al. Cancer Cell Int  (2016) 16:39 
ASPE promotes apoptosis in MDA‑MB‑231 cells
MDA-MB-231 cells were treated with different concen-
trations (10, 25 and 50 µg/mL) of ASPE for 24 h. Apop-
totic cells were determined by flow cytometry using 
Annexin V-FITC/PI double labeling. As shown in (Fig. 4), 
the percentage of the apoptotic cells increased signifi-
cantly in a dose-dependent manner. Apoptotic cells per-
centages were: 10.6 % at 10 µg/mL, 20.6 % at 25 µg/mL, 
and 50 % at 50 µg/mL vs. 2.5 % for the control cell cul-
tures. About 7 % of cell population treated with 50 µg/mL 
of ASPE showed necrotic signs (Fig. 4).
Apoptosis induction is regulated through the activation 
of active‑Caspase‑3 and inhibition of Bcl‑2 protein 
following ASPE exposure
Because ASPE induced a pronounced cell death/apop-
tosis at higher concentrations (50  µg/mL), we inves-
tigated the expression of active-Caspase-3, a crucial 
protein in apoptosis induction, at 50 and 100  µg/mL to 
better understand the mechanistic of ASPE signalling. 
We showed that ASPE induces high levels of active-
Caspase-3 protein expression starting significantly at 
50 µg/mL ASPE to attend 20-folds of expression change 
at 100 µg/mL ASPE exposure (Fig. 5a). Thus, these data 
suggest that Active-Caspase-3 might be involved in the 
ASPE-induced apoptosis of MDA-MB-231 cells. The 
down-regulation of Bcl-2 protein at same concentra-
tions was also confirmed by flow cytometry which was 
decreased in a dose-dependent manner (Fig. 5b).
ASPE exposure induces disruption in mitochondrial 
Bax:Bcl‑2 ratio and generates the production of reactive 
oxygen species (ROS) in MDA‑MB‑231 cells
We also followed up the ASPE signalling by inspecting 
the expression of mitochondrial Bax (pro-apoptotic) and 
Bcl-2 (anti-apoptotic) related to apoptosis induction at 
50 and 100 µg/mL. Here, we showed that ASPE induces 
a significant misbalance of Bax:Bcl-2 transcripts ratio of 
ASPE-treated cells by up-regulation of Bax gene to reach 
4.1-fold and down-regulation of Bcl-2 gene to reach 1.76-
fold (Fig.  6a). In the other hand, the effect of treatment 
of MDA-MB-231 cells with ASPE on the induced lev-
els of ROS was inspected by using Amplex Red™ assay. 
ROS concentration was determined in treated and lysed 
cells to measure the total ROS released by the cells. In 
this assay, cells treated with 50 and 100  µg/mL ASPE 
Fig. 3 Expression analysis of cyclin/Cdks and Cdks inhibitory (Ckis) genes in ASPE-treated MDA-MB-231 cells. Cells were exposed to 10 and 30 µg/mL 
of ASPE for 24 h. Change in gene expression in MDA-MB-231 cells of tested genes is mentioned in diagrams as fold change (ratio of target/reference 
gene). The results were divided in three groups: cyclin gene, cyclin-dependent kinase genes (Cdks) and cyclin-dependent kinase inhibitory genes 
(Ckis). Each data point represents the mean (±SEM) of three independent experiments. Asterisks indicate significant difference (P < 0.05)
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displayed a marked increase in the levels of total ROS 
levels compared to the untreated control cells. ASPE was 
able to increase the ROS signal depending on concentra-
tions tested (Fig.  6b). Therefore, these data suggest that 
the disruption of mitochondria function by the misbal-
ance of Bax:Bcl-2 ratio and ROS induction are involved 
in the ASPE-induced apoptosis of MDA-MB-231 cells.
Discussion
Algal sulfated polysaccharides have attracted more atten-
tion due to their immune modulatory and anti-tumor 
properties [26–28]. Seaweed polysaccharides are presented 
by alginates, agars, carrageenans, ulvanes, and fucoidans, 
which are widely used in the food and pharmaceutical 
industry and also in other branches of industry [29].
Several recent studies have illustrated the anti-prolif-
erative effect of polysaccharides deviated from differ-
ence resources. Polysaccharides from Tupistrachinensis 
induced severe apoptosis in a cancerous tissue in H22 
hepatocarcinoma mice animal model [30]. Other study 
revealed that, the polymeric black tea polyphenols 
modulate TAP-induced molecular and biochemical alter-
ations in mouse skin like the activation of transcription 
factors related to cell proliferation, apoptosis and inflam-
mation [31]. Although, fucoidan (sulfated polysaccharide 
obtained from brown seaweeds) induced apoptosis, inhib-
ited angiogenesis and suppressed lung metastasis of breast 
cancer in 4T1 mouse breast cancer cells and in BALB/c 
mice bearing breast cancer [32]. Even though, sulfated 
polysaccharide fraction from the brown alga Laminaria 
japonicacan effectively inhibited the proliferation of cervi-
cal carcinoma U14 cells in vitro, and could not only signif-
icantly inhibited the growth of U14 implanted tumor but 
also induced apoptosis of tumor tissue in tumor-bearing 
mice [33].
Our results showed that ASPE from red seaweed sup-
presses cell proliferation of MDA-MB-231 cells and arrest 
them at G1-phase at low dose (10 µg/ml). ASPE also trig-
gers apoptosis in these cells at higher doses (30–50  µg/
ml), possibly through enhanced expression of Bax, and 
inhabitation of Bcl-2 protein. The increased ratio of Bax/
Bcl-2 and the activation of Caspase-3 in addition to ROS 
Fig. 4 ASPE triggers apoptosis in MDA-MB-231 cells. Flow cytometric Annexin-V/PI binding profiles of untreated (Cont) or treated cells with ASPE 
at concentrations 10 µg/mL (C10), 25 µg/mL (C25) and 50 µg/mL (C50) for 24 h. Each data point represents the mean (±SEM) of three independent 
experiments. Asterisks indicate significant difference (P < 0.05)
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induction are perceptible indicators for such pathway 
(Fig. 7).
The same behaviour of treated-MDA-MB-231/Her-2 
cancers cells with curcumin (a hydrophobic polyphenol 
derived from the plant, curcuma longa) was observed 
depending on the concentration of the applied treatment. 
This compound induces G1-phase arrest at a 30  μM 
whereas, it triggers apoptosis at 50  μM and blocks cell 
migration. A low dose of curcumin cause increases p27 
and decreases Skp2, Her2, Cyclin E, CDK kinases in a 
Fig. 5 Analysis of apoptotic molecules in treated MDA-MB-231 cells. Flow cytometric expression profile of ACTIVE Caspase-3 (a), Bcl-2 (b) in 
MDA-MB-231 cells. Untreated (Cont) or treated with 50 µg/mL (C50) and 100 µg/mL (C100) for 24 h. The gray overlapping histogram represents the 
isotype control. Quantification of expression is expressed as a percentage of total viable cells of the control with each data point representing the 
mean (±SEM) of three independent experiments. Asterisks indicate significant difference (P < 0.05)
Fig. 6 Analysis of mitochondrial apoptotic molecules in treated MDA-MB-231 cells. Untreated (Cont) or treated cells with ASPE at 50 µg/mL (C50) 
and 100 µg/mL (C100). a Comparison of change in expression of Bax and Bcl-2 genes is mentioned in diagrams as fold change (ratio of target/
reference gene) in MDA-MB-231 cells. Each data point represents the mean (±SEM) of three independent experiments. b ROS measurement by 
Amplex Red™. Cells were treated with different concentrations of ASPE and incubated for 12 h. The difference between absorbance for treated and 
untreated cells samples was measured with a fluorescence-based microplate reader using excitation at 530 ± 12.5 nm and fluorescence detection 
at 580 ± 25 nm. The determined for a no-H2O2 control reaction, was subtracted from each value. The Graph demonstrates the percentage of H2O2 
from Amplex Red assay based on mean absorbance. Each data point in all diagrams is representing the mean (±SEM) of three independent experi-
ments. Asterisks indicate significant difference (P < 0.05)
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time and dose-dependent manner. However, higher doses 
of curcumin initiate a dose-dependent apoptotic death in 
MDA-MB-231 by cleaving forms of PARP and Caspase-3 
[34].
Importantly, control of cell cycle progression in cancer 
cells is considered to be a potentially effective strategy for 
the control of tumor growth [35]. The molecular analyses 
of human cancers have revealed that cell cycle regulators 
are frequently mutated in most common malignancies 
[36]. Our data indicated that treatment of MDA-MB-231 
cells at 10 µg/mL ASPE resulted in significant G1-phase 
arrest of cell cycle progression, which indicates that one 
of the mechanisms by which ASPE may act to inhibit 
the proliferation of cancer cells is inhibition of cell cycle 
progression.
Many other compounds have the same effects as ASPE 
on MDA-MB-231 cells. Boehmeriasin A isolated from 
Boehmeria siamensis Craib for example considered as 
proliferation inhibitor of MDA-MB-231 via G1 phase cell 
cycle arrest. It also induced differentiation in those cells 
[37]. Physcion (anthraquinone from rhubarb) is another 
example. This compound also has anti-proliferative 
effects on MDA-MB-231 mediated by inducing G0/G1 
phase arrest [38].On the other hand, both fractions (pen-
tane and pentane/diethyl ether fractions) which isolated 
from Daucuscarota inhibits cell proliferation by inducing 
cell cycle arrest in MDA-MB-231 cells through the inhi-
bition of the MAPK/ERK pathway [39].
When cells are injured, CDK inhibitory genes are up-
regulated then, the G1-phase-related Cyclin-CDK com-
plexes are down-regulated for promoting cell cycle arrest 
[40]. Our finding of a significant decrease in cyclins D1, 
D2, and E1 and their related inhibitors Cdk2, Cdk4, and 
Cdk6 in MDA-MB-231 cells after treatment with ASPE 
suggests the disruption of the uncontrolled cell cycle pro-
gression of these cells (Fig. 3). Therefore, this result sug-
gests that the ASPE induced G1-phase arrest is mediated 
through the up-regulation of Cip1/p21 and Kip1/p27 
transcripts, which enhances the formation of heterotrim-
eric complexes with the G1-S Cdks and cyclins thereby 
inhibiting their activity (Fig. 3). Kip1/p27 is up-regulated 
in response to anti-proliferative signals [41]. Zhuang et al. 
demonstrated that treatment of human breast cancer cell 
lines with Metformin (oral anti-hyperglycemic drug) acti-
vated AMPK which caused the loss of cyclin D1 mRNA 
and downregulation of cyclin D1 protein. The reduction 
in cyclin D1 resulted in the release of sequestered cell 
cycle inhibitors Kip1/p27 and Cip1/p21. The released 
CDK inhibitors bind to and inhibit cyclin E/CDK2, thus 
preventing cell cycle progression from G1 to S phase [42].
The increased expression of G1 cyclins in cancer cells 
provides an uncontrolled growth advantage because 
Fig. 7 Proposed pathway of ASPE signaling in MDA-MB-231 cells. Diagram indicates: Induction of G1-phase cell cycle arrest and apoptosis in MDA-
MB-231 cells. Low dose (10 µg/ml) of ASPE induce G1-phase arrest accompanied by up-regulation of Cip1/p21 and Kip1/p27 and down-regulation of 
cyclin D, and cyclin E transcripts and their related inhibitors Cdk2, Cdk4, and Cdk6.High dose (50 µg/ml) induce apoptosis in MDA-MB-231 cells and 
increase the expression of cleaved Caspase-3and Bax, and decrease the anti-apoptosis protein level of Bcl-2. Over-generation of reactive oxygen 
species ROS was also illustrated. Black triangles indicate up-regulation or down-regulation of gene/protein expression where the amplitude of 
triangle illustrates the fold change of expression
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most of these cells either lack Cdk inhibitors or the 
expression of Cdk inhibitors is not at a sufficient level to 
control Cdk-cyclin activity [40]. G1-phase arrest of cell 
cycle progression provides an opportunity for cells to 
either undergo repair mechanisms or follow the apop-
totic pathway.
The tumor suppressor TP53 plays an important role in 
response to DNA damage and other genomic instability. 
Functional TP53 protein is crucial in TP53-dependent 
pathway leading to cell cycle arrest or apoptosis [43]. 
MDA-MB-231 cells are known to contain mutated, func-
tionally inactive TP53 [44, 45]. The increase in TP53 
protein following ASPE treatment (data not shown) may 
not solely explain TP53-dependent apoptosis. There-
fore, the up-regulation of Cip1/p21 gene, cell cycle arrest 
and apoptosis in MDA-MB-231 cells is chiefly mediated 
through a TP53-independent mechanism.
On the other hand, our flow cytometry data indicate 
that treatment of MDA-MB-231 cells with 25 and 50 µg/
mL of ASPE resulted in significant induction of apopto-
sis (Fig. 4). Apoptosis plays a crucial role in eliminating 
the mutated neoplastic and hyperproliferating neoplas-
tic cells from the system and therefore is considered as 
a protective mechanism against cancer progression [46, 
47]. Apoptosis has been shown as a significant way of 
cell death after cytotoxic drug treatment in a variety of 
cancer types [48]. Therefore, an understanding of apop-
tosis events and its pathway may allow the development 
of novel agents for cancer treatment [49]. Nuclear con-
densation, DNA fragmentation, cell shrinkage and cell 
membrane disintegration are common apoptotic fea-
tures [50–52]. Interestingly, our results demonstrated 
that ASPE effectively induces apoptosis by dose and time 
dependent manner in MDA-MB-231 cells (Fig. 4). Apop-
tosis is tightly regulated by anti-apoptotic and proapop-
totic effector molecules, including Caspase-3 and Bcl-2 
protein family. As the activity of the regulatory molecules 
can be lost in cancer cells, it is important to elucidate the 
mechanisms by which anti-apoptotic molecules exert 
their effects, especially in MDA-MB-231 cells. Thus, we 
investigated the ASPE mode-of-action and by conse-
quent described the characterized apoptosis induction 
in ASPE-treated cells. We found that ASPE treatment 
of MDA-MB-231 cells resulted in a dose-dependent 
activation of Caspase-3 demonstrated by flow cytom-
etry (Fig. 5). This confirmed the role of Caspase-3 in the 
ASPE-induced apoptosis.
The Bcl-2 family of proteins is the central regulators of 
the mitochondrial cell-intrinsic apoptotic [53]. The Bcl-2 
itself binds to pro apoptotic members such as Bax, pre-
venting pore formation and cytochrome c release [54–
56]. In contrast, increase in expression of Bax, induces 
cell death eliminating tumor cells [57–59]. Therefore, 
we investigated the contribution of Bcl-2 family proteins 
to ASPE-induced apoptosis of MDA-MB-231 cells. We 
found that treatment of MDA-MB-231 cells with ASPE 
resulted in a pronounced increase in the expression of 
Bax transcripts and a decrease in the transcripts expres-
sion of Bcl-2 (Fig.  6a). Consequently, we confirmed the 
decrease of Bcl-2 protein after ASPE treatment by flow 
cytometry (Fig. 5b). This misbalance may be responsible 
for the concomitant execution phase of apoptosis that 
we observed, which included disruption of mitochon-
dria functionality. ROS generation in apoptosis induc-
tion by some agents has been shown to occur downs 
mitochondrial disruption [60, 61]. Our results also 
showed that ASPE induced ROS in a dose-dependent 
manner (Fig.  6b). ROS may as well participate in apop-
tosis induced by ASPE. Similar results were observed 
in human umbilical vein endothelial cells (HUVECs) 
exposed to high concentration of λ-carrageenan oli-
gosaccharides (λ-CO) which activated the mitochon-
drial-mediated apoptotic pathway and triggered ROS 
production [62]. Overviewing our data together, the 
biological activity of ASPE algal extract demonstrates 
a potent mechanism for cell cycle arrest and apopto-
sis induction. These results are conformed to numerous 
studies mentioning cytostatic effects within algal sulfated 
polysaccharides treatment [63, 64].
Conclusions
The results of this study do support a pervious study 
about the role of algal sulphated polysaccharidic extract 
ASPE in inducing cell cycle arrest and apoptosis induc-
tion in MDA-MB-231 breast cancer cells. The ASPE 
could be a promising target molecule for developing a 
new anti-cancer drugs. Nevertheless, further studies are 
warranted to evaluate its potential anti-proliferative and 
anti-cancerous activities in vivo.
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